These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39276018)

  • 1. AlzDiscovery: A computational tool to identify Alzheimer's disease-causing missense mutations using protein structure information.
    Pan Q; Parra GB; Myung Y; Portelli S; Nguyen TB; Ascher DB
    Protein Sci; 2024 Oct; 33(10):e5147. PubMed ID: 39276018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization on the oncogenic effect of the missense mutations of p53 via machine learning.
    Pan Q; Portelli S; Nguyen TB; Ascher DB
    Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38018912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the performance of computational predictors for estimating protein stability changes upon missense mutations.
    Iqbal S; Li F; Akutsu T; Ascher DB; Webb GI; Song J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinact: a computational approach for predicting activating missense mutations in protein kinases.
    Rodrigues CH; Ascher DB; Pires DE
    Nucleic Acids Res; 2018 Jul; 46(W1):W127-W132. PubMed ID: 29788456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alz-Disc: A Tool to Discriminate Disease-causing and Neutral Mutations in Alzheimer's Disease.
    Kulandaisamy A; Parvathy Dharshini SA; Gromiha MM
    Comb Chem High Throughput Screen; 2023; 26(4):769-777. PubMed ID: 35619290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hdWGCNA and Cellular Communication Identify Active NK Cell Subtypes in Alzheimer's Disease and Screen for Diagnostic Markers through Machine Learning.
    Song G; Wu H; Chen H; Zhang S; Hu Q; Lai H; Fuller C; Yang G; Chi H
    Curr Alzheimer Res; 2024; 21(2):120-140. PubMed ID: 38808722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants.
    Iqbal S; Pérez-Palma E; Jespersen JB; May P; Hoksza D; Heyne HO; Ahmed SS; Rifat ZT; Rahman MS; Lage K; Palotie A; Cottrell JR; Wagner FF; Daly MJ; Campbell AJ; Lal D
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28201-28211. PubMed ID: 33106425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.
    Seuma M; Faure AJ; Badia M; Lehner B; Bolognesi B
    Elife; 2021 Feb; 10():. PubMed ID: 33522485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease.
    Somavarapu AK; Kepp KP
    J Neurochem; 2016 Apr; 137(1):101-11. PubMed ID: 26756738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.
    Giau VV; Bagyinszky E; Yang YS; Youn YC; An SSA; Kim SY
    Sci Rep; 2019 Jun; 9(1):8368. PubMed ID: 31182772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare missense mutations in ABCA7 might increase Alzheimer's disease risk by plasma membrane exclusion.
    Bossaerts L; Hendrickx Van de Craen E; Cacace R; Asselbergh B; Van Broeckhoven C
    Acta Neuropathol Commun; 2022 Mar; 10(1):43. PubMed ID: 35361255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating network, sequence and functional features using machine learning approaches towards identification of novel Alzheimer genes.
    Jamal S; Goyal S; Shanker A; Grover A
    BMC Genomics; 2016 Oct; 17(1):807. PubMed ID: 27756223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDMPred: a tool for predicting cancer driver missense mutations with high-quality passenger mutations.
    Wang L; Sun H; Yue Z; Xia J; Li X
    PeerJ; 2024; 12():e17991. PubMed ID: 39253604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pathogenic missense mutations using protein stability predictors.
    Gerasimavicius L; Liu X; Marsh JA
    Sci Rep; 2020 Sep; 10(1):15387. PubMed ID: 32958805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
    Mercatanti A; Lodovichi S; Cervelli T; Galli A
    FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    Wang F; Xu CS; Chen WH; Duan SW; Xu SJ; Dai JJ; Wang QW
    J Alzheimers Dis; 2021; 83(1):163-178. PubMed ID: 34308907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
    Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A
    Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation and association analyses of dementia-causal genes in Han Chinese patients with early-onset and familial Alzheimer's disease.
    Wang G; Zhang DF; Jiang HY; Fan Y; Ma L; Shen Z; Bi R; Xu M; Tan L; Shan B; Yao YG; Feng T
    J Psychiatr Res; 2019 Jun; 113():141-147. PubMed ID: 30954774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
    Hoogmartens J; Hens E; Engelborghs S; Vandenberghe R; De Deyn PP; Cacace R; Van Broeckhoven C;
    Neurobiol Aging; 2021 Mar; 99():100.e17-100.e23. PubMed ID: 33023779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.